300630 Hainan Poly Pharm
- 14.53
- 0.000.00%
Hainan Poly Pharm News
Puli Pharmaceuticals: Notice on receiving the Hainan Securities Regulatory Bureau's decision to order the company to take corrective administrative supervision measures
Puri Pharmaceuticals: Notice on the US Food and Drug Administration (FDA) marketing approval for a supplementary application for new specifications for iopamol injections (intravascular administration)
Puli Pharmaceuticals: Announcement on the Company\'s Obtaining the “Pharmaceutical GMP Compliance Inspection Notice”
Puri Pharmaceuticals: Announcement on obtaining marketing approval from the US Food and Drug Administration (FDA) for phenylephrine hydrochloride injections
Puli Pharmaceuticals: Notice on obtaining marketing approval from the US Food and Drug Administration (FDA) for benzenesulfonium atracurium injection
Prixetam: Announcement on the temporary approval of the US Food and Drug Administration (FDA) for bricetam injections
Puli Pharmaceuticals: Announcement on obtaining marketing approval from the US Food and Drug Administration (FDA) for lacosamide injections
Puli Pharmaceuticals: Announcement of Resolutions of the 24th Meeting of the Fourth Board of Directors
Puli Pharmaceuticals: Announcement of Resolutions of the 15th Meeting of the Fourth Board of Supervisors
Puli Pharmaceutical: Feasibility analysis report of Hainan Puli Pharmaceutical Co., Ltd. on developing foreign exchange hedging business
Puli Pharmaceuticals: Inspection Opinions of Haitong Securities Co., Ltd. on Hainan Puli Pharmaceutical Co., Ltd.\'s use of some idle funds raised to temporarily supplement working capital
Puli Pharmaceuticals: Inspection Opinions of Haitong Securities Co., Ltd. on Hainan Puli Pharmaceutical Co., Ltd. and its wholly-owned subsidiaries carrying out foreign exchange hedging business
Puli Pharmaceuticals: Announcement on the use of some temporarily idle funds raised to supplement working capital
Puli Pharmaceuticals: Announcement on the company\'s intention to apply for a comprehensive credit line from the bank
Prednisolone Pharmaceuticals: Announcement on Acyclovir Sodium Injection Obtaining Marketing Approval from the US Food and Drug Administration (FDA)
Primobil Pharmaceuticals: Announcement on Nimodipine Injection Passing the Conformity Evaluation of Generic Drugs
Prednisolone Pharmaceuticals: Announcement on the US Food and Drug Administration (FDA) marketing approval for voriconazole dry suspensions
Puli Pharmaceuticals: Announcement on the return of idle funds raised to temporarily supplement working capital
Pulley Pharmaceuticals: 300630 Pulley Pharmaceuticals Investor Relations Management Information 20231204
Pulley Pharmaceuticals: Announcement on oseltamivir phosphate capsules obtaining marketing approval from the US Food and Drug Administration (FDA)
Analysis
Price Target
No Data
